RN1201 Injection

RN1201 · Tianjin Medical University Cancer Institute and Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RN1201 Injection, covering 2025-08-06 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma [Phase 1]